Effects of Solarplast (R) Supplementation on Biomarkers of Muscle Damage, Inflammation and Recovery of Physical Performance Following High-intensity Resistance Exercise
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 46
- 试验地点
- 2
- 主要终点
- Creatine Kinase Activity
研究概览
简要总结
The primary goal of this investigation is to assess whether Solarplast (R) supplementation will improve recovery following heavy resistance exercise in active adults. The primary questions to be addressed are:
Does Solarplast (R) decrease muscle damage and inflammation associated with heavy resistance exercise?
Does Solarplast (R) reduce the decline in performance associate with heavy resistance exercise?
Researchers will compare Solarplast (R) to a placebo (a look-alike substance that contains no active ingredients) to see if Solarplast (R) is effective at improving recovery.
Participants will be asked to:
Take Solarplast (R) or placebo daily for 4 weeks
Visit the laboratory at least once per week to receive their supplement
Report to the lab for 3 consecutive visits following supplementation to complete a heavy resistance training session and follow-up testing.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 35 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Recreationally-active (participated in at least 2 weight training workouts per week over the previous year) and participates in at least 3h of total structured exercise/week as determined by the health and activity questionnaire.
- •Subject is judged by the Investigator to be healthy and free of any physical limitations (determined by health and activity questionnaire)
- •Subject has a body mass index of 18.0-34.9 kg/m2, inclusive
- •Subject is willing to maintain habitual diet throughout the study period
- •Subject is willing to abstain from dietary supplementation throughout the duration of the study.
- •Subject understands the study procedures and signs forms providing informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigators
排除标准
- •Subject is currently or will be enrolled in another clinical trial.
- •Subject is a habitual consumer of tea/antioxidants defined as > 8 oz/day of either green or black tea within the 14 days prior to the screening visit.
- •Subject has a history or presence of a clinically relevant cardiac, renal, hepatic, endocrine (including diabetes mellitus), pulmonary, biliary, gastrointestinal, pancreatic, or neurologic disorder.
- •Subject has a history or presence of cancer in the prior 2 years, except for non-melanoma skin cancer.
- •Subject is unable to perform physical exercise (determined by health and activity questionnaire)
- •Subject is engaged in an extreme diet including but not limited to, Atkins, South Beach, Intermittent Fasting, etc.
- •Subject is allergic to the study product or placebo
- •Subject is taking any other nutritional supplement or performance enhancing drug (determined from health and activity questionnaire)
- •Subject has any chronic illness that causes continuous medical care
- •Taking any type of prescription or over-the-counter medication including but not limited to corticosteroids, non-steroidal anti-inflammatory drugs, and antibiotics within the 14 days prior to the screening visit.
结局指标
主要结局
Creatine Kinase Activity
时间窗: Acute changes following exercise for 48 hours
Marker of Muscle Damage
次要结局
- Peak Isometric Muscle Force(Acute changes following exercise for 48 hours)
- Ratings of Perceived Soreness(Acute changes following exercise for 48 hours)
- Ratings of Perceived Fatigue(Acute changes following exercise for 48 hours)
- Mean Squat Velocity(Acute changes following exercise for 48 hours)
- Vertical Jump Height(Acute changes following exercise for 48 hours)
- Rate of Force Development(Acute changes following exercise for 48 hours)
- Myoglobin Concentration(Acute changes following exercise for 24 hours)
研究者
Adam Jajtner
Associate Professor
Kent State University